XOMA Stock (NASDAQ:XOMA)
Previous Close
$27.77
52W Range
$13.48 - $30.36
50D Avg
$27.06
200D Avg
$23.72
Market Cap
$339.20M
Avg Vol (3M)
$25.89K
Beta
0.92
Div Yield
$2.16 (1.62%)
XOMA Company Profile
XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with approximately 70 assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.
XOMA Performance
Peer Comparison
| Ticker | Company |
|---|---|
| SIOX | Sio Gene Therapies Inc. |
| TALS | Tourmaline Bio, Inc. |
| DYN | Dyne Therapeutics, Inc. |
| RVMD | Revolution Medicines, Inc. Warrant |
| DBTX | Decibel Therapeutics, Inc. |
| ACHL | Achilles Therapeutics plc |
| EWTX | Edgewise Therapeutics, Inc. |
| STOK | Stoke Therapeutics, Inc. |
| ACRV | Acrivon Therapeutics, Inc. Common Stock |
| PASG | Passage Bio, Inc. |
| CCCC | C4 Therapeutics, Inc. |
| CRNX | Crinetics Pharmaceuticals, Inc. |
| DSGN | Design Therapeutics, Inc. |
| RZLT | Rezolute, Inc. |
| HOWL | Werewolf Therapeutics, Inc. |
| VINC | Vincerx Pharma, Inc. |
| THRD | Third Harmonic Bio, Inc. |
| CELC | Celcuity Inc. |
| TNGX | Tango Therapeutics, Inc. |
| ELYM | Eliem Therapeutics, Inc. |